As illustrated in Figure 10b, TIGD1 expression was linked to cell proliferation in AML and ALL, inflammation in AML, RB, and renal cell carcinoma (RCC), and DNA repair and damage pathways in RB and UM. Here, TIGD1 is linked to renal cell carcinoma.